Fedorova, L., Mikhailova, N., Lepik, K., Markelov, V., Chekalov, A., Smykova, O., Tumyan, G., Semenova, A., Arakelyan, A., Butaev, L., Oleinik, I., Nikitin, E., Ptushkin, V., Mangasarova, Y., Magomedova, A., Gitelzon, E., Gabeeva, N., Koroleva, D., Smolyaninova, A., Zvonkov, E., Osipov, I., Stepanova, N., Krinitsina, T., Ryabukhina, Y., Khusainova, G., Mukharliamova, L., Smirnova, O., Ishmatova, I., Zverkova, A., Elkhova, S., Volchenkov, S., Ziuzgin, I., Ivanova, D., Baryakh, E., Misyurina, E., Zeynalova, P., Abbasbeyli, F., Timofeeva, O., Podmankova, I., Ulianova, M., Basmanova, V., Tsyganok, T., Samarina, S., Kimaikina, V., Zubkova, E., Ovanesian, S., Iskhakova, A., Kuvshinov, A., Kuzyaeva, A., Isaeva, G., Andrievskih, M., Arzhanukhina, O., Makarovskaya, P., Samoylova, O., Vasileva, I., Terekhova, A., Falaleeva, N., Shuvaev, V., Vlasova, S., Lapin, V., Bakhtina, V., Kulagin, A. (2025). Real-world outcomes of glofitamab therapy in CAR-T naive patients with relapsed/refractory B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-1961